|
A more recent version of this article appeared on October 1, 2005
Papers In Press, published online ahead of print July 16, 2005
J. Lipid Res., doi:10.1194/jlr.M500201-JLR200
Submitted on May 19, 2005
Revised on July 15, 2005
Accepted on July 15, 2005
Polymorphism of the AHSG gene is associated with increased adipocyte beta2-adrenoceptor function
Catharina Lavebratt, Elisabeth Dungner, and Johan Hoffstedt
Department of Medicine, Karolinska Institutet, Stockholm 141 86
Corresponding Author: johan.hoffstedt{at}medhs.ki.se
Background: The Alpha2 Heremans-Schmid glycoprotein (AHSG) gene is implicated in regulation of body fat and insulin sensitivity. The Met/Met genotype of the common single nucleotide polymorphism (SNP), rs4917, in the AHSG-gene has been shown associated with reduced plasma levels as well as lower body fat. Here, we studied the association of this variation with subcutaneous adipocyte lipolysis. Methods: Ninety-three obese and non-obese healthy men were genotyped for Thr230Met and subcutaneous adipose tissue biopsies were analysed for lipolysis characteristics. Results: The Met/Met-genotype was associated with a marked 1.5 log units increase in the lipolytic sensitivity to the beta2-adrenoceptor agonist terbutaline (p=0.0008) as compared to the Thr/Thr and Thr/Met-genotypes. This corresponds to approximately a 35-fold increase in beta2-adrenoceptor function. The genotype effect was independent of body mass index and waist circumference. In contrast, lipolytic sensitivity to both the beta1-adrenoceptor agonist dobutamine (p=0.25) and the alpha2A-adrenoceptor agonist clonidine (p=0.54) was unaffected by the Thr230Met variation. Moreover, no difference in either maximal stimulation or inhibition of lipolysis was found between genotypes. Conclusions: A common variation (Thr230Met) in the AHSG gene is associated with a marked increase in beta2-adrenoceptor sensitivity in subcutaneous fat cells, which may be of importance in body weight regulation.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. Andersen, K. S. Burgdorf, T. Sparso, K. Borch-Johnsen, T. Jorgensen, T. Hansen, and O. Pedersen
AHSG Tag Single Nucleotide Polymorphisms Associate With Type 2 Diabetes and Dyslipidemia: Studies of Metabolic Traits in 7,683 White Danish Subjects
Diabetes,
May 1, 2008;
57(5):
1427 - 1432.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. B. Lehtinen, K. P. Burdon, J. P. Lewis, C. D. Langefeld, J. T. Ziegler, S. S. Rich, T. C. Register, J. J. Carr, B. I. Freedman, and D. W. Bowden
Association of {alpha}2-Heremans-Schmid Glycoprotein Polymorphisms with Subclinical Atherosclerosis
J. Clin. Endocrinol. Metab.,
January 1, 2007;
92(1):
345 - 352.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|